Nav: Home

ESF's EMRC calls for the adoption of open access in biomedical sciences

October 22, 2012

The European Science Foundation's (ESF) membership organisation for all medical research councils in Europe, the European Medical Research Concils (EMRC) has today released an ESF-EMRC Science Policy Briefing (SPB) entitled 'Open Access in Biomedical Research' highlighting the need to accelerate the adoption of open access to research articles in the biomedical sciences across Europe.

Over the past few months, various reports and communications have been published on the topic of open

access. These include the Finch Group report on 18 June 2012, the Publishing and the Ecology of European Research (PEER) final report on 19 June 2012, the European Research Council (ERC) announcement of its new open access policy on 13 July 2012, and the European Commission's launch of a communication and recommendations to Member States 'Towards better access to scientific information' on 17 July 2012. On the same day, Science Europe reaffirmed its commitment to strengthening the European Research and recognised open access as a priority area in which a common policy and action plan will be developed and implemented.

"The Internet and the technological developments that have arisen from it in recent years have the potential to radically change science publishing and maximise the impact of research" said Professor Pär Omling, ESF President and Science Europe Vice-President. He continued: "We envisage a full open access future - one in which all published research generated by science researchers in the European Union is immediately available online and accessible by all."

The ESF-EMRC Science Policy Briefing entitled 'Open Access in Biomedical Research' was instigated to examine whether there are new opportunities for open access in biomedical research within Europe that will benefit European biomedical researchers and European society as a whole. The report provides three key recommendations for the adoption of open access policy:

1. There is a moral imperative for open access

Research papers should be made freely available to all to read, use and re-use, with appropriate acknowledgement, in order to maximise the value of biomedical research, build on the body of knowledge, accelerate the process of discovery and improve human health.

2. Individual agencies must work together to raise awareness of the moral imperative for open access

Agencies and organisations that fund and perform research, libraries, publishers and researchers must work collectively to raise awareness of the moral imperative for open access publishing. Enhanced efforts towards national, European and international partnerships are the basis for the successful achievement of open access to research outputs.

3. All research stakeholders should work together in order to support the extension of Europe PubMed Central into a Europe-wide PubMed Central

In order to facilitate discoveries and innovation in biomedical research, research stakeholders should collaborate to establish a Europe-wide repository in biomedicine as a partner site to the US equivalent PubMed Central. The recently rebranded Europe PubMed Central represents a valuable means to achieving this goal, provided that the diversity of European partner mandates and policies can be integrated.

Professor Josef Syka, Chair of the Science Policy Briefing and EMRC Core Group member, commented: "The turnover of information in biomedical sciences is very fast, so rapid delivery of information is needed at a fair price. Open access publishing has the potential to revolutionise the way in which biomedical scientists publish and access the latest results. The EMRC supports open access publishing as the ultimate goal to maximise the discoverability process, the access to and the re-use of biomedical research results in Europe."
The Science Policy Briefing "Open Access in Biomedical Research" can be downloaded here:

Notes to editors

For more information, please contact:
Shira Tabachnikoff
European Science Foundation
Phone: +33 (0)3 88 76 71 32
Email: stabachnikoff[at]

About ESF

The European Science Foundation (ESF) is an independent, non-governmental organisation that promotes collaboration in scientific research, funding of research and science policy across Europe. Its members are 78 national funding and research-performing organisations and learned societies from 30 countries.

About EMRC The European Medical Research Councils (EMRC) is the membership organisation for all the Medical Research Councils in Europe under the ESF. The mission of the EMRC is to promote innovative medical research and its clinical application towards improved human health.

European Science Foundation

Related Biomedical Research Articles:

Advances in cryo-EM materials may aid cancer and biomedical research
Cryogenic-Electron Microscopy (cryo-EM) has been a game changer in the field of medical research, but the substrate, used to freeze and view samples under a microscope, has not advanced much in decades.
World-first program uncovers errors in biomedical research results
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research.
Scientists poised to study reproducibility of Brazilian biomedical research
A project to assess the reproducibility of biomedical research in Brazil has been described today in the open-access journal eLife.
Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.
Fitness tracker data can enhance biomedical research and personalized health
In a research article publishing February 27 in the open access journal PLOS Biology, Weng Khong Lim and colleagues from the SingHealth Duke-NUS Institute of Precision Medicine, Singapore, and the National Heart Centre Singapore show that wearable sensors are not only able to identify groups of volunteers with similar patterns of daily activity, but can also predict various markers of risk for cardiovascular diseases such as obesity, high blood pressure and high blood sugar.
As private funding of biomedical research soars, new risks arise
Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.
BGRF scientists co-publish research paper on blockchain & AI for biomedical applications
Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.
Promising new drug for Hep B tested at Texas Biomedical Research Institute
Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection.
Academic biomedical research community should take action to build resilience to disasters
The academic biomedical research community should improve its ability to mitigate and recover from the impacts of disasters, says a new report from the National Academies of Sciences, Engineering, and Medicine.
Public funding research key to advancing biomedical innovation
A new paper co-authored by Columbia University Mailman School of Public Health's Bhaven Sampat, PhD, shows that 30 percent of all NIH-funded grants produce research that is cited by a private-sector patent.
More Biomedical Research News and Biomedical Research Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at